About Faeth Therapeutics
Faeth Therapeutics is a data-driven, evidence-based company that specializes in mechanistic understanding of the way that dietary nutrients influence tumor growth and cancer treatment. It fully focuses on matching specific diets with tumor genotypes and treatment regimens to improve the outcomes of cancer therapy.
The company was founded to translate breakthrough discoveries made by cancer research laboratories into clinical practice. Its founding team includes some of the industry’s preeminent researchers and clinicians.
Company details
Funding
Total raised
$92M
Last stage
Series A
Investors
Founders
Anand Parikh
Corporate lawyer by training with prior experience at Virta Health as Head of Finance, General Counsel & Corporate Secretary. Holds a BA from University of Michigan and JD from NYU School of Law.
LinkedIn
Oliver Maddocks
Cancer Research UK Research Fellow and Group Leader at the University of Glasgow Institute of Cancer Sciences. Specializes in cancer metabolism and amino acid starvation as a therapeutic strategy.
LinkedInSiddhartha Mukherjee
Pulitzer Prize-winning physician-scientist and professor at Columbia University Irving Medical Center. One of Faeth's scientific founders alongside Lewis Cantley, Karen Vousden, Scott Lowe, and Greg Hannon.
Lewis Cantley
Discoverer of the PI3K signaling pathway and director of Weill Cornell's Meyer Cancer Center; one of the world's leading cancer biologists.
What happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.